{"id":"https://openalex.org/W2154604904","doi":null,"title":"Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.","display_name":"Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.","publication_year":2003,"publication_date":"2003-04-01","ids":{"openalex":"https://openalex.org/W2154604904","mag":"2154604904","pmid":"https://pubmed.ncbi.nlm.nih.gov/12852722"},"language":"en","primary_location":{"id":"pmid:12852722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12852722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Netherlands journal of medicine","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/1871/22905","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084481574","display_name":"Annemarie Becker\u2010Commissaris","orcid":"https://orcid.org/0000-0003-4405-5102","observed_orcids":["https://orcid.org/0000-0003-4405-5102"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A Becker","raw_affiliation_strings":["Institute for Research in Extramural Medicine, Free University Medical Centre, De Boelelaan 1117, 1008 HV Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Research in Extramural Medicine, Free University Medical Centre, De Boelelaan 1117, 1008 HV Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043556034","display_name":"Ferdinand E E Van Der Does","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F E E van der Does","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112245045","display_name":"Victor W.M. van Hinsbergh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"V W M van Hinsbergh","raw_affiliation_strings":["VU University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113467761","display_name":"Robert J. Heine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R J Heine","raw_affiliation_strings":["VU University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032296470","display_name":"L.M. Bouter","orcid":"https://orcid.org/0000-0002-2659-5482","observed_orcids":["https://orcid.org/0000-0002-2659-5482","https://orcid.org/0000-0002-2231-7637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L M Bouter","raw_affiliation_strings":["Epidemiology and Data Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epidemiology and Data Science","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016620300","display_name":"Coen D.A. Stehouwer","orcid":"https://orcid.org/0000-0001-8752-3223","observed_orcids":["https://orcid.org/0000-0001-8752-3223"]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C D A Stehouwer","raw_affiliation_strings":["Vrije Universiteit Amsterdam"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vrije Universiteit Amsterdam","institution_ids":["https://openalex.org/I865915315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7954,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.73088098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"61","issue":"4","first_page":"129","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.47780001163482666,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.47780001163482666,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.4765999913215637,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.029899999499320984,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9490000009536743},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8309999704360962},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.9890000224113464},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8769999742507935},{"id":"https://openalex.org/keywords/albumin-creatinine-ratio","display_name":"albumin-creatinine ratio","score":0.9179999828338623},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.7699999809265137},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/proinsulin","display_name":"proinsulin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.8050000071525574},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8349999785423279},{"id":"https://openalex.org/keywords/atherothrombotic-risk","display_name":"atherothrombotic risk","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8873826265335083},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8300974369049072},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.7427999377250671},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6913443207740784},{"id":"https://openalex.org/C90061646","wikidata":"https://www.wikidata.org/wiki/Q426173","display_name":"Proinsulin","level":3,"score":0.6802070140838623},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.5990918874740601},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5772002935409546},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5768341422080994},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.5623741149902344},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5383585095405579},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.5380575060844421},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5038740038871765},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5035771727561951},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.15101680159568787}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011384","descriptor_name":"Proinsulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014841","descriptor_name":"von Willebrand Factor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":10,"locations":[{"id":"pmid:12852722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12852722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Netherlands journal of medicine","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/6523e835-c897-441d-8974-9976e94fa43e","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/6523e835-c897-441d-8974-9976e94fa43e","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Becker, A, van der Does, F E E, van Hinsbergh, V W M, Heine, R J, Bouter, L M & Stehouwer, C D A 2003, 'Improvement of glycaemic control in type 2 diabetes : Favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, von Willebrand factor and (pro)insulin', Netherlands Journal of Medicine, vol. 61, no. 4, pp. 129-136.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.ubvu.vu.nl:1871/22905","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1871/22905","pdf_url":"http://hdl.handle.net/1871/22905","source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"61","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:research.vu.nl:openaire/4dccf43e-f930-4f36-bb90-cebc31c42693","doi":null,"is_oa":true,"landing_page_url":"https://research.vu.nl/en/publications/4dccf43e-f930-4f36-bb90-cebc31c42693","pdf_url":"https://research.vu.nl/ws/files/2888266/263541.pdf","source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Becker, A, van der Does, F E E, van Hinsbergh, V W M, Heine, R J, Bouter, L M & Stehouwer, C D A 2003, 'Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, von Willebrand factor and (pro)insulin', The Netherlands Journal of Medicine, vol. 61, no. 4, pp. 129-136.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu:oai:research.vu.nl:publications/4dccf43e-f930-4f36-bb90-cebc31c42693","doi":null,"is_oa":true,"landing_page_url":"https://research.vu.nl/en/publications/4dccf43e-f930-4f36-bb90-cebc31c42693","pdf_url":"https://research.vu.nl/en/publications/4dccf43e-f930-4f36-bb90-cebc31c42693","source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Netherlands Journal of Medicine, 61(4), 129 - 136. Van Zuiden Communications BV","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/f3467a0f-92a1-4058-b3b4-bfbdbecfb3a8","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/f3467a0f-92a1-4058-b3b4-bfbdbecfb3a8","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Becker, A, van der Does, F E E, van Hinsbergh, V W M, Heine, R J, Bouter, L M & Stehouwer, C D A 2003, 'Improvement of glycaemic control in type 2 diabetes : Favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, von Willebrand factor and (pro)insulin', Netherlands journal of medicine, vol. 61, no. 4, pp. 129-136.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu2:oai:dare.ubvu.vu.nl:1871/22905","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1871/22905","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Netherlands Journal of Medicine, 61(4), 129","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu:oai:research.vu.nl:publications/d00fe422-b992-4369-9f8c-a69140e37911","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/d00fe422-b992-4369-9f8c-a69140e37911","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Netherlands Journal of Medicine, 61(4), 129 - 136. Van Zuiden Communications BV","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/6523e835-c897-441d-8974-9976e94fa43e","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/6523e835-c897-441d-8974-9976e94fa43e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Netherlands Journal of Medicine, 61(4), 129 - 136. Van Zuiden Communications BV","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2154604904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12852722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:dare.ubvu.vu.nl:1871/22905","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1871/22905","pdf_url":"http://hdl.handle.net/1871/22905","source":{"id":"https://openalex.org/S4306400546","display_name":"Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"61","raw_type":"Article / Letter to editor"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2154604904.pdf","grobid_xml":"https://content.openalex.org/works/W2154604904.grobid-xml"},"referenced_works_count":69,"referenced_works":["https://openalex.org/W2707883","https://openalex.org/W69884986","https://openalex.org/W100479432","https://openalex.org/W1969930998","https://openalex.org/W1970448338","https://openalex.org/W1973331125","https://openalex.org/W1974752290","https://openalex.org/W1974816229","https://openalex.org/W1987505479","https://openalex.org/W1987649584","https://openalex.org/W1991868051","https://openalex.org/W1995937915","https://openalex.org/W1997394878","https://openalex.org/W1997801013","https://openalex.org/W1998606065","https://openalex.org/W2001284023","https://openalex.org/W2002252109","https://openalex.org/W2004047207","https://openalex.org/W2019631323","https://openalex.org/W2022351209","https://openalex.org/W2025001402","https://openalex.org/W2032571661","https://openalex.org/W2034134890","https://openalex.org/W2046809996","https://openalex.org/W2048254086","https://openalex.org/W2051674344","https://openalex.org/W2056507272","https://openalex.org/W2063869708","https://openalex.org/W2063988943","https://openalex.org/W2078089300","https://openalex.org/W2081143213","https://openalex.org/W2081175377","https://openalex.org/W2083387155","https://openalex.org/W2084124265","https://openalex.org/W2086305057","https://openalex.org/W2087967133","https://openalex.org/W2099777569","https://openalex.org/W2101603352","https://openalex.org/W2104055366","https://openalex.org/W2108646653","https://openalex.org/W2109958712","https://openalex.org/W2110626952","https://openalex.org/W2115271679","https://openalex.org/W2115480613","https://openalex.org/W2116404316","https://openalex.org/W2120842197","https://openalex.org/W2127851511","https://openalex.org/W2141913731","https://openalex.org/W2152420062","https://openalex.org/W2156273859","https://openalex.org/W2164415771","https://openalex.org/W2165430196","https://openalex.org/W2169257907","https://openalex.org/W2201395584","https://openalex.org/W2251234016","https://openalex.org/W2324579467","https://openalex.org/W2337454357","https://openalex.org/W2398649041","https://openalex.org/W2400661044","https://openalex.org/W2400762151","https://openalex.org/W2402965734","https://openalex.org/W2410639234","https://openalex.org/W2413129925","https://openalex.org/W2414440707","https://openalex.org/W2415951048","https://openalex.org/W2473215176","https://openalex.org/W2769264260","https://openalex.org/W3140821316","https://openalex.org/W4234853462"],"related_works":["https://openalex.org/W2031568163","https://openalex.org/W2073767579","https://openalex.org/W1966190642","https://openalex.org/W2301660257","https://openalex.org/W2914090669","https://openalex.org/W4255878413","https://openalex.org/W2064166365","https://openalex.org/W2055857221","https://openalex.org/W2105039884","https://openalex.org/W2028816906"],"abstract_inverted_index":{"BACKGROUND:":[0],"Diabetes":[1],"mellitus":[2],"causes":[3],"a":[4,106,117],"substantial":[5],"increase":[6],"in":[7,22,25,53,164,173,180,184,202,253,255,265,272,287,298],"cardiovascular":[8,34,66,72,152,289],"risk,":[9],"which":[10,296],"can":[11],"only":[12],"partly":[13],"be":[14,221],"reduced":[15],"by":[16],"antihyperglycaemic":[17,302],"treatment.":[18],"We":[19],"were":[20,101,187],"interested":[21],"whether":[23],"improvement":[24,31,252],"glycaemic":[26,54],"control":[27,55],"is":[28,259,280],"associated":[29,78,260,283,293],"with":[30,79,261,284,294],"of":[32,63,125,151,159,226],"other":[33,59],"risk":[35,67,73,153,290],"factors.":[36],"Therefore,":[37],"we":[38,143],"studied":[39],"among":[40],"type":[41,80,97,256],"2":[42,81,98,257],"diabetic":[43,99],"patients":[44,100],"the":[45,49,58,90,131,140,145,181,213,224,227],"association":[46],"between":[47,139,229],"on":[48,57,148,223],"one":[50],"hand":[51,60],"changes":[52,62,150,172,201,264,286],"and":[56,69,89,155,179,208,231],"within-subject":[61,149],"both":[64],"classic":[65],"factors":[68,154],"less":[70,118],"conventional":[71],"indicators":[74,156,291],"that":[75,251],"are":[76],"typically":[77,292],"diabetes":[82,258],"(proinsulin,":[83],"insulin,":[84,206],"fibrinogen,":[85],"von":[86,209],"Willebrand":[87,210],"factor":[88],"urinary":[91],"albumin-creatinine":[92,182,275],"ratio).":[93],"METHODS:":[94],"The":[95],"214":[96],"randomly":[102],"assigned":[103],"to":[104,238],"either":[105],"strict":[107,119],"fasting":[108],"capillary":[109],"glucose":[110],"target":[111,120],"level":[112],"(<":[113,121],"6.5":[114],"mmol/l)":[115],"or":[116],"8.5":[122],"mmol/l).":[123],"Duration":[124],"follow-up":[126],"was":[127],"two":[128],"years.":[129],"Since":[130],"interventions":[132],"did":[133],"not":[134,198,281,305],"yield":[135],"statistically":[136,199],"significant":[137,169,262],"differences":[138],"treatment":[141,303],"arms,":[142],"reanalysed":[144],"data":[146],"focusing":[147],"across":[157],"tertiles":[158],"average":[160],"HbA(1c).":[161],"RESULTS:":[162],"Individuals":[163],"whom":[165],"HbA(1c)":[166],"decreased":[167],"had":[168,195],"favourable":[170,263,285],"concurrent":[171],"triglycerides,":[174,266],"total":[175,267],"cholesterol,":[176,204,268],"blood":[177,269],"pressure,":[178],"ratio":[183],"those":[185],"who":[186],"normoalbuminuric":[188,273],"at":[189],"baseline.":[190],"In":[191,212,277],"contrast,":[192,278],"these":[193],"individuals":[194],"unfavourable,":[196],"although":[197],"significant,":[200],"HDL":[203],"proinsulin,":[205],"fibrinogen":[207,216,230],"factor.":[211],"whole":[214],"group,":[215],"increased":[217],"more":[218],"than":[219],"could":[220],"expected":[222],"basis":[225],"relationship":[228],"age,":[232],"namely":[233],"from":[234],"3.5":[235],"+/-":[236,240],"0.8":[237],"3.9":[239],"0.9":[241],"g/l":[242],"(p":[243],"value":[244],"<":[245],"0.01).":[246],"CONCLUSIONS:":[247],"Our":[248],"results":[249],"suggest":[250],"glycaemia":[254],"pressure":[270],"and,":[271],"individuals,":[274],"ratio.":[276],"it":[279],"consistently":[282],"some":[288],"diabetes,":[295],"may":[297],"part":[299],"explain":[300],"why":[301],"does":[304],"clearly":[306],"lower":[307],"atherothrombotic":[308],"disease":[309],"risk.":[310]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}